(Q34738902)

4 August 2017

title

A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment (English)

1 reference

neuroleptic malignant syndrome

4 August 2017

main subject

1 reference

Petzinger GM

1

1 reference

4 August 2017

Bressman SB

series ordinal

2

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 March 1997

1 reference

4 August 2017

1 reference

4 August 2017

volume

12

1 reference

4 August 2017

issue

2

1 reference

4 August 2017

page(s)

246-248

1 reference

Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870120219

Neuroleptic Malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870120219

An atypical course of neuroleptic malignant syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870120219

Pathogenesis and treatment of neuroleptic malignant syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870120219

21 January 2018

The serotonin syndrome

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870120219

Fluoxetine and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMDS.870120219

21 January 2018

Identifiers

DOI

10.1002/MDS.870120219

1 reference

4 August 2017

1 reference